Vanguard Group’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $311M | Buy |
|
|||||
|
2022
Q2 | $144M | Buy |
|
|||||
|
2022
Q1 | $128M | Buy |
|
|||||
|
2021
Q4 | $186M | Buy |
|
|||||
|
2021
Q3 | $82.8M | Sell |
|
|||||
|
2021
Q2 | $65.1M | Sell |
|
|||||
|
2021
Q1 | $249M | Buy |
|
|||||
|
2020
Q4 | $294M | Buy |
|
|||||
|
2020
Q3 | $251M | Buy |
|
|||||
|
2020
Q2 | $208M | Buy |
|
|||||
|
2020
Q1 | $89.6M | Buy |
|
|||||
|
2019
Q4 | $82.3M | Buy |
|
|||||
|
2019
Q3 | $12.8M | Buy |
|
|||||
|
2019
Q2 | $16.5M | Buy |
|
|||||
|
2019
Q1 | $17.9M | Sell |
|
|||||
|
2018
Q4 | $14.8M | Buy |
|
|||||
|
2018
Q3 | $16.8M | Buy |
|
|||||
|
2018
Q2 | $16.3M | Buy |
|
|||||
|
2018
Q1 | $16.6M | Sell |
|
|||||
|
2017
Q4 | $7.36M | Buy |
|
|||||
|
2017
Q3 | $9.14M | Buy |
|
|||||
|
2017
Q2 | $11.3M | Buy |
|
|||||
|
2017
Q1 | $8.73M | Buy |
|
|||||
|
2016
Q4 | $8.52M | Buy |
|
|||||
|
2016
Q3 | $6.76M | Buy |
|
|||||
|
2016
Q2 | $4.86M | Buy |
|
|||||
|
2016
Q1 | $2.54M | Buy |
|
|||||
|
2015
Q4 | $7.74M | Buy |
|
|||||
|
2015
Q3 | $5.71M | Buy |
|
|||||
|
2015
Q2 | $7.12M | Buy |
|
|||||
|
2015
Q1 | $6.41M | Buy |
|
|||||
|
2014
Q4 | $5.65M | Buy |
|
|||||
|
2014
Q3 | $3.49M | Buy |
|
|||||
|
2014
Q2 | $4.38M | Buy |
|
|||||
|
2014
Q1 | $4.88M | Buy |
|
|||||
|
2013
Q4 | $3.65M | Buy |
|
|||||
|
2013
Q3 | $2.65M | Buy |
|
|||||
|
2013
Q2 | $6.64M | Buy |
|